HORIZON: A French descriptive cohort of 663 patients treated for melanoma with pembrolizumab with a focus on the mucosal subgroup (n=59).
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.9563
Abstract: 9563Background: Advanced mucosal melanoma is a rare subgroup of tumors for which few data on immune therapeutic approaches is available as they are rarely or not included in pivotal trials. Pembrol... read more here.
Keywords: subgroup; horizon french; mucosal; french descriptive ... See more keywords